Tirzepatide injection pen used to improve blood sugar control in type 2 diabetes. 2.5 mg starting dose.
Contains tirzepatide, a dual GIP/GLP-1 receptor agonist. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Attributes
Product Content
How to Use:
• Inject subcutaneously once weekly in the abdomen, thigh, or upper arm, any time of day, with or without food.
• This 2.5 mg strength is the starting dose, used for 4 weeks; it is not a maintenance dose.
• Dose is then increased in 2.5 mg increments every 4+ weeks, up to a maximum of 15 mg weekly.
• Rotate injection sites with each dose.
The link to Mounjaro KwikPen 2.5mg 1 Prefilled Pen (Refrigerated) has been copied